RADVAX™: A STRATIFIED PHASE I/II DOSE ESCALATION TRIAL OF HYPOFRACTIONATED RADIOTHERAPY FOLLOWED BY IPILIMUMAB IN METASTATIC MELANOMA
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Clinical Trials Related to Metastatic Melanoma
Related studies linked through entity extraction aliases.
Trial of Vemurafenib/Cobimetinib With or Without Bevacizumab in Patients With Stage IV BRAFV600 Mutant Melanoma
- Status
- TERMINATED
- Phase
- PHASE2
Melanoma Treatment With White Blood Cells That Destroy MART Expressing Tumor Cells
- Status
- TERMINATED
- Phase
- PHASE2
Immunotherapy Using Tumor Infiltrating Lymphocytes for Patients With Metastatic Melanoma
- Status
- TERMINATED
- Phase
- PHASE2
Modified White Blood Cells That Secrete IL-2 and Express a Protein That Targets the ESO-1tumor Protein for Metastatic Cancer
- Status
- TERMINATED
- Phase
- PHASE1
Study of MLN2480 in Participants With Relapsed or Refractory Solid Tumors Followed by a Dose Expansion in Participants With Metastatic Melanoma
- Status
- COMPLETED
- Phase
- PHASE1
Study of Immune Responses in Patients With Metastatic Melanoma
- Status
- WITHDRAWN
- Phase
- PHASE2
Comparison of High-dose IL-2 and High-dose IL-2 With Radiation Therapy in Patients With Metastatic Melanoma.
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
PROCLAIM Registry to Evaluate the Treatment Patterns and Clinical Response in Malignancy
- Status
- COMPLETED
- Phase
- N/A
Use of IL-15 After Chemotherapy and Lymphocyte Transfer in Metastatic Melanoma
- Status
- TERMINATED
- Phase
- PHASE1/PHASE2
Modified Tumor Infiltrating Lymphocytes for Metastatic Melanoma
- Status
- TERMINATED
- Phase
- PHASE2
Cediranib Maleate and Selumetinib Sulfate in Treating Patients With Solid Malignancies
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1
Open-Label Study of TPI 287 for Patients With Metastatic Melanoma
- Status
- WITHDRAWN
- Phase
- PHASE1/PHASE2
Efficacy Study of Pharmacokinetic(PK)/Pharmacodynamic(PD) Relationship of Monotherapy MORAb-004 in Metastatic Melanoma
- Status
- COMPLETED
- Phase
- PHASE2
Prospective Randomized Study of Cell Transfer Therapy for Metastatic Melanoma Using Tumor Infiltrating Lymphocytes Plus IL-2 Following Non-Myeloablative Lymphocyte Depleting Chemo Regimen Alone or in Conjunction With 12Gy Total Body Irradiation (TBI...
- Status
- COMPLETED
- Phase
- PHASE2
Collection of Cerebrospinal Fluid and Tumor Tissue in Subjects With Metastatic Melanoma and Controls
- Status
- WITHDRAWN
- Phase
- N/A
Masitinib in Non-Resectable or Metastatic Stage 3/4 Melanoma Carrying a Mutation in the Juxta Membrane Domain of c-Kit
- Status
- TERMINATED
- Phase
- PHASE3
MAGE-A3/12 Metastatic Cancer Treatment With Anti-MAGE-A3/12 TCR-Gene Engineered Lymphocytes
- Status
- TERMINATED
- Phase
- PHASE1/PHASE2
Aldesleukin With or Without Ziv-Aflibercept in Treating Patients With Stage III-IV Melanoma That Cannot Be Removed by Surgery
- Status
- COMPLETED
- Phase
- PHASE2
Cell Therapy for Metastatic Melanoma Using CD8 Enriched Tumor Infiltrating Lymphocytes
- Status
- TERMINATED
- Phase
- PHASE1/PHASE2